We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Rosetta Genomics Reports In-Vivo Efficacy Data for a Systemic MicroRNA Therapeutic for Liver Cancer

News   Feb 16, 2009

 
Rosetta Genomics Reports In-Vivo Efficacy Data for a Systemic MicroRNA Therapeutic for Liver Cancer
 
 
Advertisement
 

RELATED ARTICLES

Controlled Human Infection Models for SARS-CoV-2 Vaccine Development

News

Infecting some volunteers with COVID-19 may provide valuable insights for future rounds of vaccine testing, but would require very strict controls, argues a group of infectious disease experts in the New England Journal of Medicine.

READ MORE

Trial of Saliva Test for COVID-19 Launched

News

Scientists from the Innovative Genomics Institute (IGI), the same UC Berkeley group that rapidly popped up a state-of-the-art COVID-19 testing laboratory in March, are now trialing a quicker way to obtain patient samples: through saliva.

READ MORE

Next-generation Sequencing To Provide Precision Medicine for Rare Metabolic Disorders

News

Scientists have uncovered the genetic basis of aromatase deficiency – a rare metabolic disorder – using next-generation sequencing, paving the way towards precision medicine.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE